← Back to all trials
Not Yet Recruiting
NCT07741695
Targeting IRAK4 in Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia (CLL)
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 50
Sponsor: IRCCS San Raffaele
Summary
Patients with chronic lymphocytic leukemia (CLL) followed at Strategic Research Program on CLL will be enrolled and undergo sampling of additional amount of blood at the time of standard blood tests. Leukemic B cells and peripheral blood mononuclear cells (PBMC).
Eligibility Criteria
Inclusion Criteria:
1. Age ≥18 years
2. Diagnosis of CLL
3. Participant is willing and able to give informed consent for participation in the study.
Exclusion Criteria:
1\) Participant is unable or unwilling to provide informed consent for participation in the study
Source: ClinicalTrials.gov (NCT07741695). StuddyBuddy aggregates publicly available trial information.
